Tag: Dilip Shanghvi

Sun Pharma’s $11.75 billion Organon deal set to reshape Kenyan drug market

Sun Pharma’s $11.75 billion Organon deal reshapes global pharma, with ripple effects for Kenya’s drug access and pricing dynamics.

Feyisayo Ajayi Feyisayo Ajayi